Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
Agency: Centers for Disease Control and Prevention - ERA
Assistance Listings: 93.262 -- Occupational Safety and Health Program
Last Updated: May 13, 2026
Description
The World Trade Center (WTC) Health Program supports exploratory and developmental research projects (R21) that address issues related to diagnostic or treatment uncertainty among individuals receiving monitoring and/or treatment under Subtitle C of the James Zadroga 9/11 Health and Compensation Act of 2010, as amended. This R21 Notice of Funding Opportunity (NOFO) is intended to encourage exploratory/developmental research by supporting the early and conceptual stages of project development to assess the feasibility of new areas of investigation with the potential to improve treatment effectiveness...
and diagnostic practices. These studies may lead to breakthroughs in a particular area or to the development of new interventions, techniques, agents, methodologies, models, or approaches with potential clinical impact. They are expected to break new ground or extend prior discoveries in new directions or applications. Applicants are expected to propose research for which there is likely to be minimal or no preliminary data.
Eligibility
Eligible applicants
Business
- Small businesses
- For-profit organizations other than small businesses
Government
- State governments
- Special district governments
- County governments
- City or township governments
- Federally recognized Native American tribal governments
- Public and Indian housing authorities
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
Education
- Private institutions of higher education
- Independent school districts
- Public and state institutions of higher education
Miscellaneous
- Unrestricted
Additional information
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.
Grantor contact information
Description
James Yiin, PhD, Scientific Program Official
jcy5@cdc.gov
jcy5@cdc.gov
Documents
| File name | Description | Last updated |
|---|---|---|
| rfa-oh-26-015_rev6.pdf | rfa-oh-26-015_rev6.pdf | May 8, 2026 08:24 PM UTC |
Link to additional information
--
Closing: June 23, 2026
December 8, 2026; October 26, 2027. All applications must be submitted no later than 11:59 pm local time of the applicant organization.
Award
$18,000,000
Program Funding
36
Expected awards
$--
Award Minimum
$365,000
Award Maximum
Funding opportunity number:
RFA-OH-26-015
Cost sharing or matching requirement:
No
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
--
Category of Funding Activity:
Health
Category Explanation:
--
History
Version:
1
Posted date:
May 8, 2026
Archive date:
October 27, 2027
